Insider · CIK 0001588467

Drachman Jonathan G

CIK 0001588467 Name as filed on the most recent filing

Filed as Drachman Jonathan G (18)

25 transaction lines · from 18 filings · filed 2014-01-21 to 2021-11-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

25 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-11-10 P, Open-market purchase Calithera Biosciences, Inc.CALA 171,900, acquired Open Form 4 filing 0000899243-21-044150
2021-08-25 P, Open-market purchase Neoleukin Therapeutics, Inc.NLTX 2 lines 322,450, acquired Open Form 4 filing 0001209191-21-053544
2021-08-24 P, Open-market purchase Neoleukin Therapeutics, Inc.NLTX 611,100, acquired Open Form 4 filing 0001209191-21-053544
2021-06-04 P, Open-market purchase Neoleukin Therapeutics, Inc.NLTX 96,082, acquired Open Form 4 filing 0001209191-21-038690
2021-06-03 P, Open-market purchase Neoleukin Therapeutics, Inc.NLTX 379,272, acquired Open Form 4 filing 0001209191-21-038690
2019-12-20 P, Open-market purchase Neoleukin Therapeutics, Inc.NLTX 999,995, acquired Open Form 4 filing 0000899243-19-029824
2019-09-11 P, Open-market purchase Neoleukin Therapeutics, Inc.NLTX 449,898, acquired Open Form 4 filing 0000899243-19-023329
2019-09-10 P, Open-market purchase Neoleukin Therapeutics, Inc.NLTX 113,290, acquired Open Form 4 filing 0000899243-19-023329
2019-09-09 P, Open-market purchase Neoleukin Therapeutics, Inc.NLTX 218,559, acquired Open Form 4 filing 0000899243-19-023329
2018-03-05 S, Open-market sale Seattle Genetics Inc /WASGEN 2 lines 552,452, disposed Open Form 4 filing 0001203311-18-000012
2017-08-28 S, Open-market sale Seattle Genetics Inc /WASGEN 407,199, disposed Open Form 4 filing 0001203311-17-000062
2017-08-24 S, Open-market sale Seattle Genetics Inc /WASGEN 475,414, disposed Open Form 4 filing 0001203311-17-000056
2017-07-27 S, Open-market sale Seattle Genetics Inc /WASGEN 545,361, disposed Open Form 4 filing 0001203311-17-000036
2017-06-22 S, Open-market sale Seattle Genetics Inc /WASGEN 2 lines 640,058, disposed Open Form 4 filing 0001203311-17-000032
2016-11-09 S, Open-market sale Seattle Genetics Inc /WASGEN 517,379, disposed Open Form 4 filing 0001203311-16-000173
2016-11-01 S, Open-market sale Seattle Genetics Inc /WASGEN 176,847, disposed Open Form 4 filing 0001203311-16-000165
2016-09-22 S, Open-market sale Seattle Genetics Inc /WASGEN 127,631, disposed Open Form 4 filing 0001203311-16-000161
2016-08-22 S, Open-market sale Seattle Genetics Inc /WASGEN 185,943, disposed Open Form 4 filing 0001203311-16-000129
2015-08-20 S, Open-market sale Seattle Genetics Inc /WASGEN 187,513, disposed Open Form 4 filing 0001203311-15-000048
2014-08-24 S, Open-market sale Seattle Genetics Inc /WASGEN 120,718, disposed Open Form 4 filing 0001327763-14-000009
2014-02-20 S, Open-market sale Seattle Genetics Inc /WASGEN 66,083, disposed Open Form 4 filing 0001203311-14-000020
2014-01-16 S, Open-market sale Seattle Genetics Inc /WASGEN 54,946, disposed Open Form 4 filing 0001203311-14-000011

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 10
  • Open-market sale 15
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. DRACHMAN JONATHAN G, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001588467

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.